Phenoxybenzamine
Back to searchMolecule Structure
Scientific Name
Phenoxybenzamine
Description of the Drug
Phenoxybenzamine is an alpha adrenergic antagonist used to treat pheochromocytoma and episodes of hypertension and sweating.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00925
http://www.drugbank.ca/drugs/DB00925
Brand Name(s)
Not Available
Company Owner(s)
Concordia Pharmaceuticals Inc, Par Pharmaceutical Inc, Amneal Eu Ltd, Hikma Pharmaceuticals Usa Inc, Novitium Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha | PROTEIN FAMILY | ANTAGONIST | CHEMBL2095203 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5722 | ||
| PharmGKB | PA450919 | ||
| Human Metabolome Database | HMDB0015061 | ||
| DrugBank | DB00925 | ||
| PubChem: Thomson Pharma | 14873959 | ||
| PubChem | 4768 | ||
| Mcule | MCULE-1084779069 | ||
| LINCS | LSM-1729 | ||
| Nikkaji | J4.795C | ||
| BindingDB | 50017679 | ||
| EPA CompTox Dashboard | DTXSID0023458 | ||
| DrugCentral | 2136 | ||
| Brenda | 160292 | ||
| ChemicalBook | CB1933947 | ||
| Guide to Pharmacology | 7268 | ||
| rxnorm | PHENOXYBENZAMINE | PHENOXYBENZAMINE HYDROCHLORIDE | DIBENZYLINE |
| KEGG Ligand | C07435 | ||
| ChEBI | 8077 |
